Investing
Large cryptocurrencies were mixed during morning trading on Thursday, with Cardano Cardano USD seeing the biggest move, shedding 3.12% to 36 cents. Polygon Polygon...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
Investing
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s highlights of the most timely ETF news emailed to you weekly....
Investing
In these times of deep divisions, one thing Americans can agree on is the Super Bowl. It has become our secular version of Carnival...
Investing
A glimmer of hope appeared Friday for beleaguered New York Community Bancorp after its stock rose 17% on strong trading volume. Investors seemed reassured...
Investing
U.S. auto sales are expected to be stronger than a year ago, but set to decline compared with April as concerns simmer about the...
Investing
The investor entered a position in Illumina ILMN and added to the Southwest Gas investment. He curbed the holdings of Herc Holdings and Newell...
Investing
Macy’s Inc. is bringing Nike products back to certain stores and e-commerce operations in the fall and will further scale the offering to additional...
Investing
Macy’s Inc.’s stock erased early losses to trade flat Thursday, after the department-store chain posted weaker-than-expected fiscal first-quarter sales and cut its full-year guidance...
Investing
Market divergences can lead investors to chase high flying stocks at a peak. As we wrap up May, we find that key market indices...
Investing
Nvidia Corp. Chief Executive Jensen Huang exuded confidence on Thursday that the chip maker has what it takes to navigate the geopolitical sensitivities of...
Investing
Imagine, for a moment, that the following hypothetical headline described the current state of our economy: US in Recession: High Prices Drive Household Spending...
Investing
Michael Novogratz, chief executive at crypto investment manager Galaxy Digital, said while bitcoin and ether ETHUSD have recently been rangebound with low trading volume,...
Investing
Medicare on Thursday announced plans for coverage of new Alzheimer’s drugs whose accessibility has become a point of controversy. For drugs that are granted...
